Baxter Executive and Leadership Team

Anita Zielinski, the Interim Chief Financial Officer, Senior Vice President, Chief Accounting Officer & Controller at Baxter, manages the entire financial architecture of the organization. Zielinski directs global accounting practices, internal controls, and financial reporting standards to ensure absolute transparency for stakeholders. By overseeing capital allocation and fiscal planning, the Interim Chief Financial Officer, Senior Vice President, Chief Accounting Officer & Controller maintains the economic health required to support the development of complex medical devices and pharmaceuticals. Anita Zielinski monitors liquidity and risk management protocols, providing the necessary stability for long-term investment in healthcare technology. Through rigorous oversight of corporate controllership, the executive ensures compliance with international regulatory requirements. This leadership role stabilizes the balance sheet while enabling the company to pursue strategic growth initiatives across diverse global markets, ultimately securing the financial foundation for all medical manufacturing operations.

Andrew Frye, the Senior Vice President & President (APAC) at Baxter, directs all commercial operations and market expansion strategies throughout the Asia-Pacific region. Frye architects localized distribution networks for infusion systems and surgical technologies, ensuring that hospitals and clinics receive critical care products efficiently. By managing regional partnerships and regulatory engagement, the Senior Vice President & President (APAC) drives significant revenue growth across diverse healthcare landscapes. Andrew Frye aligns regional product offerings with specific clinical needs, optimizing the delivery of injectable therapies to meet rising demand. This leadership role involves coordinating with global supply chain teams to maintain consistent product availability across the APAC territory. Through strategic market penetration and operational excellence, Frye strengthens the company presence in emerging economies, ensuring that medical providers have reliable access to advanced patient monitoring solutions and life-saving hospital care products.

Stacey Eisen, the ​Senior Vice President, Chief Communications Officer and Corporate Marketing, and President, Baxter Foundation at Baxter, manages the global brand identity and corporate reputation. Eisen directs integrated marketing campaigns that highlight the value of medical devices and pharmaceuticals to healthcare providers worldwide. By overseeing internal and external communications, the ​Senior Vice President, Chief Communications Officer and Corporate Marketing, and President, Baxter Foundation ensures consistent messaging regarding the company mission. Stacey Eisen also leads the philanthropic efforts of the foundation, driving social impact initiatives that align with the broader healthcare goals of the organization. This leadership role involves engaging with key stakeholders, including investors and clinical partners, to articulate the strategic vision of the company. Through effective brand positioning and community outreach, Eisen fosters trust and awareness, supporting the overall market impact of the diverse portfolio of hospital care products.

Cecilia Soriano, the Group President, Infusion Therapies Technologies & Pharmaceuticals at Baxter, directs the research, development, and manufacturing of core infusion systems and injectable therapies. Soriano architects the product roadmap for advanced medical technologies, ensuring that clinical solutions meet the evolving needs of hospitals and healthcare providers. By overseeing the lifecycle of pharmaceutical products, the Group President, Infusion Therapies Technologies & Pharmaceuticals drives innovation in patient monitoring and drug delivery systems. Cecilia Soriano coordinates with engineering and clinical research teams to maintain high standards of safety and efficacy in all manufactured goods. This leadership role involves scaling production capabilities to meet global demand while maintaining rigorous quality control protocols. Through the strategic management of these critical product lines, Soriano ensures that the company remains a leader in the medical device industry, providing essential tools that improve patient care and clinical outcomes.